KR20110134162A - Composition for confectionery product or bread with low glycemic index and a method for preparing the same - Google Patents
Composition for confectionery product or bread with low glycemic index and a method for preparing the same Download PDFInfo
- Publication number
- KR20110134162A KR20110134162A KR1020100053995A KR20100053995A KR20110134162A KR 20110134162 A KR20110134162 A KR 20110134162A KR 1020100053995 A KR1020100053995 A KR 1020100053995A KR 20100053995 A KR20100053995 A KR 20100053995A KR 20110134162 A KR20110134162 A KR 20110134162A
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- weight
- bread
- composition
- glycemic index
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/362—Leguminous plants
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/40—Products characterised by the type, form or use
- A21D13/41—Pizzas
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/02—Treatment of flour or dough by adding materials thereto before or during baking by adding inorganic substances
- A21D2/06—Reducing agents
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/16—Fatty acid esters
- A21D2/165—Triglycerides
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/18—Carbohydrates
- A21D2/181—Sugars or sugar alcohols
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/34—Animal material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/10—General methods of cooking foods, e.g. by roasting or frying
- A23L5/15—General methods of cooking foods, e.g. by roasting or frying using wave energy, irradiation, electrical means or magnetic fields, e.g. oven cooking or roasting using radiant dry heat
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Agronomy & Crop Science (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Abstract
Description
본 발명은 저혈당지수(low glycemic index) 특성을 갖는 제과ㆍ제빵용 조성물 및 이를 제조하는 방법에 관한 것이다.The present invention relates to a confectionery and baking composition having a low glycemic index property and a method for producing the same.
본 발명을 위한 연구는 [연구사업명: 2008 유망여성과학자 지원사업, 과제고유번호: 532-2008-1-F00021, 과제명:당뇨환자를 위한 혈당조절용 스낵개발: 반응표면분석을 이용한 대두 혼합 쿠키 개발 및 당뇨환자의 혈당 조절에 미치는 영향 탐색]에 의하여 일부 지원되었다.The research for the present invention [Project name: 2008 Promising Women Scientists Support Project, Assignment No .: 532-2008-1-F00021, Title: Development of blood sugar control snack for diabetic patients: Development of soybean mixed cookie using response surface analysis And exploration of effects on blood sugar control in diabetic patients.
근래, 식품을 이용한 다이어트 및 건강관리에 대한 관심과 연구가 활발히 이루어지면서 혈당지수나 혈당부하지수의 개념이 부각되고 있다. 혈당지수(GI, Glycemic Index)는 탄수화물에 포함되어 있는 당질의 양을 기초로 혈당치 상승률을 비교한 값으로, 포도당을 먹었을 때 혈당치의 상승도를 100으로 하고 각 음식을 섭취하였을 때의 혈당치 상승을 지수로 표시하여 당질의 소화흡수 속도를 반영한 것이다. 통상, 혈당지수가 70 이상이면 고혈당지수, 56-69이면 중혈당지수, 55이하이면 저혈당지수 식품으로 분류된다. 혈당부하지수(Glycemic Load)는 당질의 흡수속도에 더하여 당질의 양을 고려하여 섭취 후의 혈당반응을 예측하는 값으로, 해당 식품의 탄수화물 함량에 혈당 지수를 곱한 값을 100으로 나누어 구한다. 고혈당부하지수는 20이상, 중혈당부하지수는 11-19, 저혈당부하지수는 10 이하로 구분된다. Recently, with interest and research on diet and health care using foods, the concept of glycemic index or glycemic load is emerging. Glycemic Index (GI) is a comparison of blood glucose increase rate based on the amount of carbohydrates in carbohydrates.It is a blood sugar level of 100 when glucose is ingested, and a blood sugar level when each food is ingested. Marked as a reflection of the digestive absorption rate of the sugar. Usually, if the glycemic index is 70 or more, it is classified as a high glycemic index, if it is 56-69 medium glycemic index, if it is 55 or less it is classified as a low glycemic index food. Glycemic load (Glycemic load) is a value that predicts the blood glucose response after ingestion in consideration of the amount of sugar in addition to the absorption rate of the sugar, divided by 100 by multiplying the carbohydrate content of the food by the glycemic index. High glycemic load is 20 or more, medium glycemic load is 11-19, low glycemic load is 10 or less.
혈당지수가 높은 식품은 혈당이 빠르게 상승하여 취장에서 인슐린 분비를 촉진하고 체지방의 축척을 촉진하나, 혈당지수가 낮은 식품은 혈당이 천천히 상승하여 췌장에서 인슐린이 천천히 분비되고 식욕억제효과 및 포만감을 준다. 따라서, 체중의 감소나 조절이 필요하거나 혈당조절을 필요로 하는 사람들은 저혈당지수의 음식을 섭취하는 것이 중요하다. 비만인들 뿐만 아니라 건강한 성인들에게도 체중의 적절한 관리를 위한 저혈당지수 식품들이 필요하다. Foods with high glycemic index increase blood sugar rapidly to promote insulin secretion and promote body fat accumulation, while foods with low glycemic index increase blood sugar slowly and release insulin slowly from pancreas and suppress appetite and satiety. . Therefore, it is important for people who need to reduce or control their weight or need glycemic control to eat foods with low glycemic index. Healthy adults, as well as obese people, need low glycemic index foods for proper weight management.
혈당지수를 고려하는 식사요법이 당뇨병의 예방, 치료 및 합병증 관리에 도움이 된다는 결과들이 보고되었다 (김인주, 대한당뇨병학회지, 제33호, p261-266, 2009). 우리나라의 당뇨환자는 전체 국민의 10%를 차지할 정도로 급속하게 증가하고 있어, 당뇨환자의 혈당조절용 기능성 식품에 대한 관심이 급증하고 있다. 미국, 유럽에서는 당뇨환자들을 위한 혈당상승억제 또는 혈당강하효과가 있는 기능성 식품이 20여년 전부터 이미 다양하게 개발되어 판매되고 있지만, 국내에서 이러한 제품의 개발은 미개척분야이다.Results have been reported that diet therapy considering glycemic index may help prevent, treat, and manage complications of diabetes (In-Joo Kim, Journal of The Korean Diabetes Association, No. 33, p261-266, 2009). The number of diabetics in Korea is increasing rapidly, accounting for 10% of the total population, and the interest in functional foods for controlling blood sugar of diabetics is increasing rapidly. In the United States and Europe, functional foods having a hypoglycemic or hypoglycemic effect for diabetics have been developed and sold for more than 20 years. However, the development of such products in the domestic market is unexplored.
한편, 음식물로 섭취된 탄수화물은 알파-아밀라제(α-amylase)에 의하여 이당류로 분해되고, 분해된 이당류는 알파-글루코시다제 (α-glucosidase)에 의해 단당류로 분해되어 혈관 내로 이동한다. 이로 인하여 혈당이 증가되고, 당뇨병의 환자일 경우 혈당을 적절하게 조절하지 못하여 여러 가지 합병증이 유발될 수 있다. 이들 저해제들은 상기 효소의 활성을 저해함으로써 식품의 탄수화물로부터 포도당 유리 및 포도당 흡수를 지연시켜 혈당지수에 유익한 효과를 가져다주고, 결과적으로 식후 혈장 글루코스 수준 (postprandial plasma glucose level)을 감소시키고 식후 과혈당증 (postprandial hyperglycemia)을 억제한다 (K Suthindhiran 등, International Journal of Integrative Biology, vol.6, No.3, p115-120, 2009; El Ashry ES 등, Pharmazie, vol. 55, p251-262, 2000).Carbohydrates ingested as food are decomposed into disaccharides by alpha-amylase, and the degraded disaccharides are decomposed into monosaccharides by alpha-glucosidase and moved into blood vessels. As a result, blood sugar is increased, and in the case of diabetics, blood sugar may not be properly controlled, and various complications may be caused. These inhibitors have a beneficial effect on the glycemic index by inhibiting the activity of the enzyme, thereby delaying glucose free and glucose absorption from carbohydrates in foods, resulting in a decrease in postprandial plasma glucose levels and postprandial hyperglycemia (postprandial). hyperglycemia) (K Suthindhiran et al., International Journal of Integrative Biology, vol. 6, No. 3, p115-120, 2009; El Ashry ES et al., Pharmazie, vol. 55, p251-262, 2000).
본 발명은 혈당상승 억제력이 높은 저혈당지수(low glycemic index) 및 저혈당부하(low glycemic load)의 특성을 갖으면서 단백질 등의 영양분을 공급할 수 있는 제과ㆍ제빵용 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a composition for confectionery and bakery, which can supply nutrients such as proteins while having low glycemic index and low glycemic load.
상기 과제를 해결하기 위하여 본 발명은 황금분말, 대두분말 또는 서리태분말과 같은 콩분말 및 이소올리고당을 포함하는 제과 또는 제빵용 조성물 및 이를 사용하여 과자 또는 빵을 제조하는 방법 및 이로 제조된 과자 또는 빵류를 제공한다.In order to solve the above problems, the present invention is a confectionery or baking composition comprising a soybean powder and isooligosaccharides such as golden powder, soybean powder or frost powder, and a method for manufacturing a confectionery or bread using the same and the confectionery or bread produced therefrom To provide.
본 발명의 일 양태는 황금분말 0.5-10중량%, 콩분말 10-40중량%, 이소말토올리고당 10-25중량%를 포함하는, 저혈당지수 및 저혈당부하지수를 갖으며 단백질 성분을 제공하는 제과ㆍ제빵용 조성물에 관한 것이다. One embodiment of the present invention has a low glycemic index and low glycemic load index, including 0.5-10% by weight of golden powder, 10-40% by weight of soybean powder, and 10-25% by weight of isomaltooligosaccharide. It relates to a baking composition.
본 발명의 다른 일 양태는 황금 분말 0.5-10중량%, 콩분말 10-40중량%, 이소말토올리고당 10-25중량%를 포함하는, 저혈당지수 및 저혈당부하지수를 갖으며 단백질 성분을 제공하는 제과ㆍ제빵용 조성물로 제조된 과자 또는 빵에 관한 것이다. Another embodiment of the present invention has a low glycemic index and low glycemic load index, including 0.5-10% by weight of golden powder, 10-40% by weight of soybean powder, 10-25% by weight of isomaltooligosaccharide, and confectionery for providing a protein component. The present invention relates to a confectionery or bread made from a baking composition.
본 발명은 또한 황금분말 0.5-10중량%, 콩분말 10-40중량%, 이소말토올리고당 10-25중량%를 포함하는 조성물을 사용하여 저혈당지수 또는 저혈당부하지수를 갖는 과자 또는 빵을 제조하는 방법을 제공한다. The present invention also provides a method for preparing a confectionery or bread having a low glycemic index or a low glycemic load index using a composition comprising 0.5-10% by weight of golden powder, 10-40% by weight of soy powder, and 10-25% by weight of isomaltooligosaccharide. To provide.
본 발명의 또 다른 양태는 황금분말 0.5-10중량%, 콩분말 10-40중량%, 이소말토올리고당 10-25중량%를 포함하는 조성물을 사용하여 비만, 당뇨병을 예방, 개선하는 방법에 관한 것이다. Another embodiment of the present invention relates to a method for preventing and improving obesity and diabetes by using a composition comprising 0.5-10% by weight of golden powder, 10-40% by weight of soy powder, and 10-25% by weight of isomaltooligosaccharide. .
본 발명에 따른 제과ㆍ제빵용 조성물 및 이로 제조된 식품은 저혈당지수 및 저혈당부하지수를 갖는다. 또한 본 발명의 조성물로 제조된 식품을 섭취할 경우 정상인 및 당뇨환자의 공복시 및 식품섭취시 혈당이 감소한다. 따라서 본 발명의 조성물 및 식품은 정상인 또는 환자의 혈당 조절용 기능성 식품 또는 체중 조절을 위한 식품으로 사용될 수 있다. 또한 본 발명의 조성물 및 이로 제조된 식품은 당뇨 또는 비만의 예방, 개선, 치료, 당뇨 또는 비만으로 인한 합병증 관리에 사용될 수 있다. 본 발명의 조성물은 단백질 성분이 풍부한 콩류를 포함하여 고영양식으로도 유용하다.The confectionery and baking composition according to the present invention and the food prepared therefrom have a low glycemic index and a low glycemic load index. In addition, when the food prepared with the composition of the present invention, fasting and food intake of normal and diabetic patients, blood sugar is reduced. Therefore, the composition and food of the present invention can be used as a functional food for controlling blood sugar or food for weight control of a normal person or a patient. In addition, the composition of the present invention and the food prepared therefrom can be used for the prevention, improvement, treatment of diabetes or obesity, and management of complications due to diabetes or obesity. The composition of the present invention is also useful as a high fat diet, including legumes rich in protein components.
이하, 본 발명을 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명에서 사용되는 모든 기술용어는, 달리 정의되지 않는 이상, 본 발명의 관련 분야에서 통상의 당업자가 일반적으로 이해하는 바와 같은 의미로 사용된다. 또한 본 명세서에는 바람직한 방법이나 시료가 기재되나, 이와 유사하거나 동등한 것들도 본 발명의 범주에 포함된다. 본 명세서에 참고문헌으로 기재되는 모든 간행물의 내용은 본 발명에 도입된다. All technical terms used in the present invention are used in the sense that they are generally understood by those of ordinary skill in the relevant field of the present invention unless otherwise defined. Also described herein are preferred methods or samples, but similar or equivalent ones are within the scope of the present invention. The contents of all publications described herein by reference are incorporated into the present invention.
본 발명의 발명자들은 지모, 천화분, 연자육, 황금의 분말의 알파-글루코시다제 억제력을 측정한 결과 황금분말이 가장 억제력이 컸으며, 기존에 알파-글루코시다제 억제제로 사용되고 있는 아카보스와 유사한 억제력을 보인다는 것을 밝혀내고 (표1), 황금분말을 본 발명의 조성물의 성분으로 선택하였다. 본 발명의 발명자들은 박력분밀가루, 설탕, 버터를 주성분으로 포함하는 일반적인 밀쿠키(대조군)와, 상기 쿠키에 알파-글루코시다제 억제 효과가 있는 황금분말을 첨가하고, 설탕을 이소말토올리고당으로 대체 및/또는 밀가루를 대두 또는 서리태 분말로 대체한 쿠키를 제조하여 정상 성인에게 각각 섭취 시키고 혈당반응 면적을 측정한 결과 시험에 사용된 쿠키섭취군 모두 대조군인 밀쿠키 섭취군과 비교하여 혈당지수가 감소하였으며, 대두 또는 서리태 분말, 황금분말, 이소말토올리고당이 모두 포함된 쿠키를 섭취시킨 경우 혈당반응의 총면적이 밀쿠키 섭취 시보다 유의적으로 낮았으며, 저혈당지수 범위(55 또는 그 이하), 저혈당부하지수(10이하) 범위에 속한다는 것을 밝혀내었다(표4). 또한, 본 발명의 발명자들은 당뇨환자에게 간식대용으로 정상인들에게서 가장 혈당상승을 낮추는 효과가 있었던 대두 또는 서리태 분말, 황금분말, 이소말토올리고당을 포함하는 쿠키를 4주간 섭취시킨 결과, 쿠키섭취를 시작하기 전과 비교하여 공복 시 혈당이 감소하며(표5), 대조군인 밀쿠키섭취군과 비교하여 쿠키 섭취로 인한 혈당상승정도가 낮다(표6)는 것을 밝혔다. The inventors of the present invention measured the inhibitory activity of alpha-glucosidase of hair, natural powder, lotus root, and golden powder, and the golden powder was the most inhibitory, and the inhibitory activity similar to that of acarbose, which was previously used as an alpha-glucosidase inhibitor, was observed. As can be seen (Table 1), golden powder was selected as a component of the composition of the present invention. The inventors of the present invention add a general wheat cookie (control group) containing a powder of flour, sugar, butter as a main ingredient, and a golden powder having an alpha-glucosidase inhibitory effect to the cookie, and replaces sugar with isomaltoligosaccharide and / Or cookies prepared with flour replaced with soy or frosted powder were fed to normal adults, respectively, and the blood glucose response area was measured. Ingestion of cookies containing, soy or frosted powder, golden powder, and isomaltooligosaccharide significantly lower the total glycemic response area than ingesting milk cookies, low glycemic index range (55 or less), low glycemic load index It was found to fall in the range of 10 or less (Table 4). In addition, the inventors of the present invention ingested cookies for 4 weeks as a result of ingesting cookies containing soy or frosted powder, golden powder, and isomaltooligosaccharide, which had the effect of lowering the blood sugar level in normal people as a snack substitute for diabetics. Compared with the following, fasting blood sugar decreased (Table 5), and compared with the control group, the milk cookie intake group, the glycemic rise due to cookie consumption was lower (Table 6).
이와 같은 실험결과를 바탕으로 본 발명은 황금분말, 콩분말, 이소말토올리고당을 포함하는, 저혈당지수 및 저혈당부하지수를 갖으며 단백질 성분을 제공하는 제과ㆍ 제빵용 조성물을 제공한다. Based on the experimental results, the present invention provides a confectionery and bakery composition including a golden powder, soybean powder, and isomaltooligosaccharide, having a low glycemic index and a low glycemic load index and providing a protein component.
본 발명의 조성물에 포함되는 황금분말은 전체 조성물의 중량 기준으로 0.1 내지 15중량%, 바람직하게는 0.5 내지 10중량%가 포함될 수 있으며, 콩분말은 5 내지 60중량%, 바람직하게는 10 내지 40중량%가 포함되며, 이소말토올리고당은 5내지 30중량%, 바람직하게는 10 내지 25중량%가 포함된다. 본 발명의 조성물의 재료를 상기 중량% 이하로 사용하면 원하는 정도의 혈당지수를 얻기 어려우며, 상기 중량% 이상으로 사용하면 식감이 우수하지 못하다. Golden powder included in the composition of the present invention may contain 0.1 to 15% by weight, preferably 0.5 to 10% by weight based on the total weight of the composition, soybean powder is 5 to 60% by weight, preferably 10 to 40 Wt% is included, and isomaltooligosaccharide is 5-30 wt%, preferably 10-25 wt%. When the material of the composition of the present invention is used in the weight% or less, it is difficult to obtain a desired glycemic index, and when used in the weight% or more, the texture is not excellent.
본 발명의 조성물에 포함되는 콩분말은 대두, 완두콩, 강낭콩, 서리태, 흑태, 약콩, 팥, 녹두, 땅콩, 청태, 동부 및 작두콩 등의 콩의 분말로부터 선택될 수 있으며 이로 제한되는 것은 아니다. 콩분말은 콩을 그대로 사용하거나 또는 볶은 후 분말화하여 제조할 수 있다. 본 발명의 조성물에 사용되는 황금분말은 황금을 건조하여 분말화하여 제조할 수 있다. Soybean powder included in the composition of the present invention may be selected from powders of soybeans, peas, kidney beans, frosted soybeans, black beans, medicinal beans, red beans, green beans, peanuts, chungtae, eastern and small beans, but is not limited thereto. Soybean powder can be prepared by using the beans or roasted and powdered. Golden powder to be used in the composition of the present invention can be prepared by drying the gold powder.
본 발명의 조성물은 황금분말, 콩분말, 이소말토올리고당 이외에 과자 또는 빵을 제조하기 위하여 필요한 추가의 재료를 포함할 수 있다. 예를 들어 밀가루, 곡분, 설탕, 버터, 마아가린, 달걀 등을 들 수 있으며 이로 제한되는 것은 아니다.The composition of the present invention may include additional ingredients necessary for preparing cookies or bread in addition to golden powder, soybean powder and isomaltooligosaccharide. Examples include, but are not limited to, flour, flour, sugar, butter, margarine, eggs, and the like.
본 발명의 제과 또는 제빵용 조성물에는 필요에 따라, 영양가를 높이거나 향미/풍미를 부여하거나, 식감개선, 보존기간 연장, 착색 목적 등으로 일반적인 식품분야에서 사용되는 각종 첨가물을 더 함유시킬 수 있다. 영양가를 높이는 것을 목적으로 하는 첨가물에는, 예를 들면, 각종 비타민류, 미네랄류 등이 포함된다. 향미/풍미를 부여하기 위한 목적으로 첨가되는 것으로는, 예를 들어, 향료, 천연감미제(소마린, 스테비아 등), 합성감미제(사카린, 수크라로스, 아스파탐 등), 간장, 된장, 화학조미료, 풍미물질(치즈, 초콜렛 등) 등이 포함된다. 착색을 목적으로하는 첨가물에는 예를 들면, 카라멜, 천연 착색료 등이 포함된다. 또한 상기 첨가물에는 식품분야에서 널리 사용되고 있는 각종 유화제(슈크로오스, 지방산에스테르, 레시틴, 글리세린지방산에스테르, 폴리글리세린지방산에스테르 등), 안정제, 방부제 등도 포함된다. 또한 상기 첨가물에는 식염, 이스트, 효소, 팽창제, 점증제, 유화제, 달걀, 탈지분유, 옥수수전분, 바닐라향, 오렌지향 등을 첨가할 수 있다. 효소로서는, 예를 들면, 제과 제빵용으로 일반적으로 잘 알려져 있는 각종의 프로테아제, 아밀라아제, 셀라제 등을 예시 할 수 있다. 팽창제로서는, 식품업계에서 널리 사용되고 있는, 예를 들어 탄산수소나트륨, 탄산수소암모늄 등과, 이들을 포함하는 것, 예를 들어 베이킹파우더를 들 수 있다. 이들 첨가제는 각각 1종을 단독으로 사용할 수 있고, 또는 2종 이상을 조합하여 사용할 수도 있다. 이들 첨가물의 배합량은 통상적으로 과자나 빵에 배합되는 양이면 좋다.If necessary, the confectionery or baking composition of the present invention may further contain various additives used in general food fields for improving nutritional value, giving flavor / flavor, improving texture, extending shelf life, coloring, and the like. Additives aimed at improving the nutritional value include various vitamins, minerals and the like. For the purpose of imparting flavor / flavour, for example, flavors, natural sweeteners (somarin, stevia, etc.), synthetic sweeteners (saccharin, sucralose, aspartame, etc.), soy sauce, miso, chemical seasonings, Flavors (such as cheese and chocolate). Additives intended for coloring include, for example, caramel, natural colorants, and the like. In addition, the additives include various emulsifiers (sucrose, fatty acid esters, lecithin, glycerin fatty acid esters, polyglycerol fatty acid esters, etc.) widely used in the food field, stabilizers, and preservatives. In addition, salt, yeast, enzymes, swelling agents, thickeners, emulsifiers, eggs, skim milk powder, corn starch, vanilla flavor, orange flavor can be added to the additive. Examples of the enzymes include various proteases, amylases, cellases, and the like, which are generally well known for confectionery baking. Examples of the swelling agent include sodium bicarbonate, ammonium bicarbonate and the like, which are widely used in the food industry, and those containing them, for example, baking powder. These additives can be used individually by 1 type, respectively, or can also be used in combination of 2 or more type. The compounding quantity of these additives should just be an amount normally mix | blended with a cake or bread.
본 발명의 조성물은 과자나 빵을 제조하기 위하여 일반적으로 사용되는 방법을 사용하여 과자나 빵을 제조할 수 있다. 예를 들어, 버터쿠키의 경우 반죽 혼합기에 버터를 투입한 다음 저속으로 혼합하고, 설탕, 난백거품의 순으로 투입하며 고속으로 혼합하고 밀가루, 콩분말, 황금분말 등의 가루를 혼합하여 성형을 하고 굽는 방법으로 제조될 수 있다. The composition of the present invention can produce a cookie or bread using a method generally used for producing a cookie or bread. For example, in the case of butter cookies, add butter to the dough mixer, mix at low speed, add sugar and egg white foam, mix at high speed, and mix flour, soybean powder, golden powder, etc. It can be produced by baking.
본 발명의 조성물로 쿠키, 비스켓, 크랙커, 웨하스류, 머핀, 스폰지케이크, 롤케이크, 도넛 및 페이스트리로 구성된 군으로부터 선택되는 과자를 제조할 수 있으며, 이로 제한되는 것은 아니다. The composition of the present invention can produce a cookie selected from the group consisting of cookies, biscuits, crackers, hawhas, muffins, sponge cakes, roll cakes, donuts and pastries, but is not limited thereto.
또한 본 발명의 조성물로는 식빵, 바게트빵, 호빵, 더치빵 및 피자도우로 구성된 군으로부터 선택되는 빵을 제조할 수 있으며, 이로 제한되는 것은 아니다. In addition, the composition of the present invention can produce a bread selected from the group consisting of bread, baguette bread, hop bread, Dutch bread and pizza dough, but is not limited thereto.
본 발명은 버터 10-20중량%와 설탕 0-10중량%를 저속에서 혼합하고, 난백 5-15중량%를 넣고 고속에서 혼합한 후, 밀가루 10-20중량%, 콩분말 10-40중량%, 황금 분말 0.5-10중량%, 이소말토올리고당 10-25중량%, 소금 0.1-1중량%, 베이킹 파우더 0.1-1중량%을 혼합하여 적당한 크기로 성형을 하고, 오븐에서 굽는 것을 포함하는 저혈당지수를 갖는 것을 특징으로 하는 과자의 제조방법 및 이 방법으로 제조된 과자를 제공한다. In the present invention, 10-20% by weight of butter and 0-10% by weight of sugar are mixed at low speed, 5-15% by weight of egg whites are mixed at high speed, 10-20% by weight of wheat flour and 10-40% by weight of soybean powder. Low glycemic index, including molding in a suitable size by mixing 0.5-10% by weight of golden powder, 10-25% by weight of isomaltooligosaccharide, 0.1-1% by weight of salt, 0.1-1% by weight of baking powder, and baking in an oven It provides a method for producing a confectionery characterized in that it has a and a confectionery produced by this method.
본 발명은 하기 실시예에 의해 더욱 상세히 설명되나, 본 발명이 이들에 의해 제한되는 것은 아니다.The invention is illustrated in more detail by the following examples, although the invention is not limited thereto.
실험예Experimental Example 1. 알파- 1.alpha- 글루코시다제Glucosidase 억제 효과를 갖는 천연물 약재의 검색 Search for Natural Herbs with Inhibitory Effect
혈당과 혈중 지질성분을 저하시키는 천연물 약재들 중 지모, 천화분, 연자육, 황금분말의 알파-글루코시다제 억제력을 측정하여 양성 대조군으로 알파글루코시다제 억제제로 사용되고 있는 아카보스(acarbose)와 비교하였다. Alpha-glucosidase inhibitory effects of hair, natural powder, lotus root and golden powder among natural products that lower blood sugar and lipid components were measured and compared with acarbose, which is used as an alphaglucosidase inhibitor as a positive control.
지모, 천화분, 연자육, 황금을 건조하여 분쇄한 후 각각의 분말 10 mg을 증류수 1ml에 첨가하였다.After crushing the dried hair, natural powder, soft meat, and gold, 10 mg of each powder was added to 1 ml of distilled water.
랫트 소장의 아세톤 분말 (Sigma Co, USA) 5mg을 0.1M maleate buffer(pH 6.9) 1ml에 녹여 얼음배스에서 30분 동안 초음파 처리하고, 11,000 rpm, 4℃에서 30분 동안 원심분리한 후 상층액을 효소기질로 사용하였다. 제조된 효소기질 50μl, 한약재 분말(지모, 천화분, 연자육 또는 황금 분말) 용액 (10mg/ml) 또는 아카보스 (10mg/ml) 용액 50μl , 0.1M maleate buffer 100μl를 (37oC) 10분 동안 미리 반응시키고, 4% 말토스(maltose) 용액 50μl를 첨가한 후 30분 더 반응시킨 후 ice에 보관하여 반응을 중지시켰다. Glucose kit(Bioclinical system, 한국)를 사용하여 알파-글루코시다제 억제능을 측정하였다. Acetone Powder in Rat Small Intestine (Sigma Co, USA) 5 mg was dissolved in 1 ml of 0.1 M maleate buffer (pH 6.9), sonicated in an ice bath for 30 minutes, centrifuged at 11,000 rpm and 4 ° C. for 30 minutes, and the supernatant was used as an enzyme substrate. . 50 μl of the prepared enzyme substrate, 50 μl of herbal medicine powder (Jimoh, natural powder, soft meat or golden powder) or 50 μl of akabose (10 mg / ml) solution, 0.1 μl maleate buffer (37 o C) for 10 minutes After adding 50 μl of a 4% maltose solution, the reaction was further stopped for 30 minutes, and then stored in ice to stop the reaction. Alpha-glucosidase inhibitory activity was measured using a Glucose kit (Bioclinical system, Korea).
지모, 천화분, 연자육, 황금 분말의 알파-글루코시다제 억제력을 측정한 결과 황금 분말이 가장 억제력이 컸으며, 연자육>천화분>지모 순서이었다. 황금분말(73.2±3.5%)은 알파-글루코시다제 억제제로 사용되고 있는 아카보스(73.2±3.5%)와 유사한 억제력을 보였다(표1). As a result of measuring alpha-glucosidase inhibitory activity of hair, natural powder, soft powder, and golden powder, golden powder was the most inhibitory, followed by soft powder> natural powder> hair. Gold powder (73.2 ± 3.5%) showed a similar inhibitory activity to acarbose (73.2 ± 3.5%) used as an alpha-glucosidase inhibitor (Table 1).
따라서 4개의 한약재 중 알파-글루코시다제 억제력이 가장 높은 황금 분말을 본 발명의 조성물의 성분으로 선택하였다.Therefore, among the four herbal medicines, the golden powder having the highest inhibitory effect of alpha-glucosidase was selected as a component of the composition of the present invention.
실험예Experimental Example 2. 쿠키의 제조 2. Preparation of Cookies
대조구인 밀쿠키는 박력분 300g, 설탕 150g, 소금 3g, 버터 150g, 베이킹파우더 3g, 난백 75g의 배합비로 하여 제조하였고, 샘플쿠키는 대두/서리태분말로 밀가루를 대체하거나, 이소말토올리고당으로 설탕을 대체하고, 황금분말을 첨가하여 표2의 배합비로 제조하였다. 반죽 혼합기에 버터를 투입한 다음 저속에서 30초, 설탕 첨가 후 고속에서 1분간 혼합 후, 난백거품을 넣고 고속에서 4분 혼합하고 가루(황금분말, 콩분말, 밀가루, 이소말토올리고당, 소금, 베이킹 파우더 혼합물)를 혼합하여 적당한 크기로 성형을 하고, 180℃에서 15분간 구었다. Milk cookie, a control, was prepared with a blending force of 300 g, 150 g of sugar, 3 g of salt, 150 g of butter, 3 g of baking powder, and 75 g of egg white. To prepare a compounding ratio of Table 2 by adding a golden powder. Put the butter into the dough mixer, mix it for 30 seconds at low speed, add sugar for 1 minute at high speed, add egg white foam and mix it for 4 minutes at high speed. Powder (golden powder, soy powder, flour, isomaltooligosaccharide, salt, baking) Powder mixture) were mixed to form a suitable size, and baked at 180 ° C. for 15 minutes.
실험예Experimental Example 3. 정상 3. Normal 성인에서In adults 쿠키 섭취 후의 혈당반응 Blood Glucose Response after Cookie Intake
배합비에 따른 쿠키를 제조하여 건강한 성인에게 섭취 후 혈당에 미치는 영향을 조사하고, 각각의 쿠키에 대한 혈당지수를 구하였다. Cookies were prepared according to the compounding ratio, and the effects on blood glucose after ingestion in healthy adults were obtained, and the glycemic index for each cookie was obtained.
건강한 성인 10명을 대상으로 실험 당일 아침 손끝에서 채혈하여 공복 시 혈당을 측정한 후 종류별 쿠키를 각각 다른 날에 섭취 후 15, 30, 45, 60, 90 및 120분에 각각 손끝에서 채혈하여 혈당을 측정하여 혈당 반응을 살펴보았다. 혈당 측정은 혈당측정계(Accu-Chek Softclix, Roche Diagnostics Co. FL, USA)로 2회 반복 측정하였으며, 혈당반응 결과를 밀쿠키(대조군)와 비교하였다. 혈당반응 결과는 밀쿠키 섭취 후 2시간 동안의 혈당반응면적과 샘플쿠키 섭취 후의 혈당반응면적을 비교하여 백분율로 계산한 것을 혈당지수로 나타내었다. 혈당반응면적은 공복시 혈당이 혈당면적에 영향을 미치지 않도록 샘플 쿠키 섭취 후 증가된 혈당면적만을 계산하고 혈당 측정 이후부터 혈당이 공복 시 혈당까지 감소될 때까지의 시간은 비례식을 이용하여 계산하였다. 혈당 부하지수는 혈당지수를 바탕으로 식품의 실제섭취량을 고려해 탄수화물의 영향을 평가하는 것으로, 혈당지수는 특정식품 내 탄수화물이 얼마나 빨리 포도당으로 분해되어 흡수되는가를 알려주는 질적인 수치로 1회 1인 섭취분량과 같은 양적인 면이 고려되어 있지 않으므로 실제 식품섭취량을 고려한 혈당부하지수를 함께 계산하였다. 당뇨환자를 위한 쿠키의 1회 섭취권장량은 47g이다. Ten healthy adults were taken at the fingertips of the morning of the experiment, measured on fasting blood sugar, and consumed cookies on different days. After 15, 30, 45, 60, 90 and 120 minutes, the blood glucose was measured at the fingertips and the blood glucose response was examined. Glucose was measured twice with a blood glucose meter (Accu-Chek Softclix, Roche Diagnostics Co. FL, USA), and the results of blood glucose response were compared with those of Milcookie (control). The glycemic response was expressed as a glycemic index calculated by comparing the area of blood glucose response for 2 hours after ingesting milk cookie with the area of blood glucose response after ingesting sample cookie. The blood glucose response area was calculated using only the increased blood glucose area after ingesting the sample cookie so that the fasting blood glucose did not affect the blood glucose area, and the time from the measurement of blood glucose until the blood sugar was reduced to the fasting blood glucose was calculated using a proportional equation. The glycemic load index is a measure of the effects of carbohydrates on the basis of the glycemic index, taking into account the actual intake of food.The glycemic index is a qualitative figure that indicates how quickly carbohydrates in a particular food are broken down and absorbed into glucose. Since quantitative aspects such as intake are not taken into account, the blood glucose load factor considering the actual food intake is calculated together. The recommended intake of cookies for diabetics is 47g.
혈당반응 면적을 측정한 결과 표 3과 같이 시험에 사용된 쿠키섭취군 모두 대조군인 밀쿠키 섭취군과 비교하여 혈당지수가 감소하였으며, 대두 또는 서리태 분말, 황금분말, 이소말토올리고당이 모두 포함된 쿠키의 섭취시 혈당반응의 총면적은 밀쿠키 섭취 시보다 유의적으로 낮은 것으로 나타났다. 쿠키 섭취 후 측정한 혈당 값으로 산출한 혈당반응곡선의 면적을 이용하여 혈당지수를 산출한 결과 대두/서리태 분말, 황금, 이소말토올리고당이 모두 혼합된 쿠키는 저당지수 범위(55 또는 그 이하)에 속하였다. As a result of measuring the area of blood glucose response, as shown in Table 3, all of the cookie intake groups used in the test had a decreased glycemic index compared to the control group of the milk cookie group, and cookies containing all of soybean or frosted powder, golden powder, and isomaltooligosaccharide. The total area of blood sugar response was significantly lower than that of milk cookies. The glycemic index was calculated using the area of the blood glucose response curve calculated from the blood sugar value measured after the ingestion of cookies. Cookies containing all of the soybean / surrey powder, gold, and isomaltoligosaccharide were included in the low glycemic index range (55 or less). Belonged.
혈당부하지수가 낮은 식품들은 혈당지수 또한 낮으나 섭취량이 많은 식품의 경우는 혈당이 크게 상승하며 인슐린 요구도가 높아지므로 질적인 개념의 당지수와 양적인 개념의 혈당부하지수를 함께 이해하는 것이 중요하다. 테스트한 쿠키 섭취군 모두 혈당부하지수가 20이하였으며, 대두 또는 서리태 분말, 황금분말, 이소말토올리고당이 모두 혼합된 쿠키의 혈당부하지수는 10이하로 나타났다. Foods with low glycemic load are also low in glycemic index, but foods with high intake have high blood sugar and insulin demand. Therefore, it is important to understand the quality of glycemic index and the quality of glycemic load. The glycemic load of the cookie-treated group was less than 20, and the glycemic load of the soy or frost powder, golden powder, and isomaltooligosaccharide was less than 10.
실험예Experimental Example 4. 당뇨 환자의 장기간 쿠키 섭취 시 혈당반응 4. Blood Sugar Response in Long-term Cookie Intake of Diabetic Patients
당뇨환자 10명에게 간식대용으로 정상인들에게서 가장 혈당상승을 낮추는 효과가 있었던 샘플3 쿠키와 샘플6 쿠키 각각을 10명씩 두 그룹으로 나누어 1일 1회 분량을 4주 동안 섭취하도록 하고, 공복시 혈당은 쿠키 섭취를 시작하기 전과 4주 동안 섭취 후 공복에 각각 측정하였다. 그리고 당뇨환자들의 쿠키 섭취 직후 혈당반응 곡선을 알아보기 위해, 12시간 공복 후 실험 당일 아침 손끝에서 채혈하여 공복 시 혈당을 측정한 후 각각의 쿠키를 섭취시키고 15, 30, 60, 90 및 120분에 각각 손끝에서 채혈하여 혈당을 측정하였다. 혈당측정은 혈당측정계(Accu-Chek Softclix, Roche Diagnostics Co., FL, USA)로 2회 반복하여 측정하였으며, 혈당반응 결과를 대조군 쿠키섭취군과 비교하였다. Ten patients with diabetes were divided into two groups of 10 samples, 3 samples and 6 cookies, each of which had the effect of lowering blood sugar in normal people as a substitute for snacks. Intake for 4 weeks, fasting blood glucose was measured on an empty stomach before starting cookie intake and after ingestion for 4 weeks, respectively. And to determine the blood glucose response curve of diabetic patients immediately after eating cookies, After fasting for 12 hours, blood was collected at the fingertips on the morning of the test day, and the fasting blood glucose was measured. Each cookie was ingested and blood glucose was measured at the fingertips at 15, 30, 60, 90 and 120 minutes, respectively. Glucose was measured twice with a blood glucose meter (Accu-Chek Softclix, Roche Diagnostics Co., FL, USA), and the blood glucose response was compared with the control cookie intake group.
1) 장기간 쿠키 섭취 전 후 공복 혈당 비교1) Comparison of fasting blood sugar before and after eating cookies for a long time
4주 동안 쿠키를 섭취하도록 하고 섭취 시작 전과 4주 섭취 후의 공복혈당을 비교한 결과, 샘플3 쿠키를 섭취한 경우 섭취 전보다 섭취 후에 유의적으로 혈당이 낮아졌으며, 샘플6 쿠키 섭취군도 혈당이 낮아지는 경향을 보였다(표4). When cookies were taken for 4 weeks and fasting blood sugar was compared between the start of the intake and the 4 weeks after ingestion, the blood glucose level was significantly lower after the ingestion of the sample 3 cookie than before the intake. The trend was shown (Table 4).
2) 4주간 쿠키 섭취한 당뇨병 2) Diabetes eating cookies for 4 weeks 환자에서In the patient 쿠키 섭취 후 시간별 혈당반응 변화 Hourly Blood Glucose Response after Cookie Intake
샘플3 또는 샘플6 쿠키 섭취군은 대조군(밀쿠키섭취군)보다 혈당이 전반적으로 낮게 나타났으며, 섭취 30분 후부터 120분까지 샘플3 쿠키 섭취군에서 혈당상승이 유의적으로 낮았고, 샘플6 쿠키섭취군 역시 혈당상승 정도가 밀쿠키 섭취군보다 낮은 것을 확인할 수 있었다. 샘플3 및 샘플6 쿠키 모두 섭취 후 120분에서 섭취 전보다 혈당이 낮아진 것을 관찰할 수 있었다(표5). The blood sugar level of the sample 3 or sample 6 cookie group was lower than that of the control group (milk cookie intake group), and the blood sugar rise was significantly lower in the sample 3 cookie group from 30 minutes to 120 minutes after ingestion. The intake group also confirmed that the blood sugar level was lower than the milk cookie intake group. Both samples 3 and 6 cookies showed lower blood sugar levels than 120 minutes after ingestion (Table 5).
제조예Manufacturing example 1: One: 비스켓Biscuits
밀가루(중력분과 박력분의 비율 3:1) 양을 100중량%로 하여 밀가루 대비 버터 50중량%, 설탕 16중량%, 소금 1중량%, 베이킹파우더 2중량%, 우유 20중량% 및 달걀 1 개로 하는 비스킷의 배합비 중에서, 밀가루 중 70중량%를 서리태 분말로 대체하고, 설탕대신 이소말토올리고당으로 완전히 대체하고 총 중량에 대하여 황금분말을 5중량%첨가하는 배합비로 조정한다. 위 배합비를 바탕으로 버터에 설탕(또는 이소말토올리고당), 소금을 넣어 부드럽게 한 후 달걀을 넣어 크림화한다. 이때 작업환경에 따라 유화제를 사용할 수 있다. 크림화 후 건재료(밀가루, 베이킹파우더, 황금분말와 우유를 넣고 부드럽게 반죽한다. 완성된 반죽은 실온, 냉장 또는 냉동실에서 일정시간 휴지 후 비스킷의 모양을 잡아 오븐에서 구워 낸다. The amount of flour (gravity and force 3: 1) is 100% by weight, and 50% by weight of butter, 16% by weight of sugar, 1% by weight of salt, 2% by weight of baking powder, 20% by weight of milk and 1 egg In the blending ratio of the biscuits, 70% by weight of the flour is replaced with frosted powder, completely replaced with isomaltoligosaccharides instead of sugar, and adjusted to the blending ratio of 5% by weight of the golden powder relative to the total weight. Based on the above formula, add butter (or isomaltooligosaccharides) and salt to butter to soften, then add eggs to cream. The emulsifier can be used according to the working environment. After creaming, knead the dry ingredients (flour, baking powder, golden powder and milk) and knead the dough. After finishing for a certain time in room temperature, refrigerated or freezer, shape the biscuits and bake them in the oven.
제조 예 2: 빵 Preparation Example 2: Bread
밀가루(강력분) 양을 100중량%로 하여 밀가루 대비 유지 4중량%, 설탕 중량6%, 소금 2중량%, 탈지분유 3중량%, 이스트 푸드 0.2중량%, 물 6중량3% 및 생이스트를 3중량%로 하는 빵의 배합비 중에서, 밀가루 양의 35%를 대두 분말로 대체하고, 설탕을 모두 이소말토올리고당으로 대체하고, 총 중량의 5%에 해당하는 황금분말을 첨가한 배합비로 조정한다. 위 배합비를 바탕으로 건재료(밀가루, 대두분말, 설탕, 소금, 이스트 푸드, 생이스트 및 탈지분유)를 물과 함께 반죽기에서 반죽한 후 유지를 첨가하여 글루텐이 형성되도록 반죽한다. 완성된 반죽은 1차 발효실(온도 30℃, 습도 75-80%)에서 발효 후 각각의 제빵 특성에 맞게 분할 후 실온에서 중간발효 시킨다. 중간발효 완료 후 성형 후 2차 발효실(온도 38℃, 습도 75-85%)에서 발효 후 오븐에 구워 낸다. Make 100% by weight of flour (strong powder), 4% by weight fat, 6% sugar, 2% salt, 3% skim milk powder, 0.2% yeast food, 6% water 3% and fresh yeast 3 In the blending ratio of the bread by weight, 35% of the amount of flour is replaced with soybean powder, all sugar is replaced with isomaltooligosaccharide, and adjusted to the blending ratio with the addition of golden powder corresponding to 5% of the total weight. Based on the above formula, dry ingredients (wheat flour, soybean powder, sugar, salt, yeast food, fresh yeast and skim milk powder) are kneaded together with water in a kneader and kneaded to form gluten by adding fat or oil. The finished dough is fermented in a primary fermentation chamber (temperature 30 ℃, humidity 75-80%) and then fermented at room temperature. After the completion of the intermediate fermentation, it is baked in an oven after fermentation in a secondary fermentation chamber (temperature 38 ° C., humidity 75-85%).
본 발명이 속하는 기술분야의 당업자는 본 발명이 그 기술적 사상이나 필수적 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 본 발명의 범위는 상기 상세한 설명을 포함하여 특허청구범위의 의미 및 범위 그리고 그 등가개념으로부터 도출되는 모든 변경 또는 변형된 형태를 포함하는 것으로 해석되어야 한다.Those skilled in the art to which the present invention pertains will understand that the present invention can be implemented in other specific forms without changing the technical spirit or essential features. The scope of the invention should be construed to include all changes or modifications derived from the meaning and scope of the claims and equivalent concepts including the above detailed description.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100053995A KR101181876B1 (en) | 2010-06-08 | 2010-06-08 | Composition for confectionery product or bread with low glycemic index and a method for preparing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100053995A KR101181876B1 (en) | 2010-06-08 | 2010-06-08 | Composition for confectionery product or bread with low glycemic index and a method for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110134162A true KR20110134162A (en) | 2011-12-14 |
KR101181876B1 KR101181876B1 (en) | 2012-09-11 |
Family
ID=45501617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100053995A KR101181876B1 (en) | 2010-06-08 | 2010-06-08 | Composition for confectionery product or bread with low glycemic index and a method for preparing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101181876B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016021897A1 (en) * | 2014-08-04 | 2016-02-11 | 신용문 | Legume cookies without any wheat flour, sugar and additives, and method for producing same |
IT201900007338A1 (en) * | 2019-05-27 | 2020-11-27 | Pietro Tassone S N C Gia’ Tassone Antonio & C S N C | Bread making process |
US11141429B2 (en) | 2016-03-15 | 2021-10-12 | American University Of Beirut | Composition and use of macro-minerals to lower postprandial glycemic response and reduce body weight |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101823524B1 (en) * | 2015-11-26 | 2018-03-14 | 세종대학교 산학협력단 | Quality characteristics of bakery products including soy processed materials |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100870538B1 (en) | 2007-07-06 | 2008-12-01 | 호서대학교 산학협력단 | Producing method for cookie of bean-curd dregs |
-
2010
- 2010-06-08 KR KR1020100053995A patent/KR101181876B1/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016021897A1 (en) * | 2014-08-04 | 2016-02-11 | 신용문 | Legume cookies without any wheat flour, sugar and additives, and method for producing same |
US11141429B2 (en) | 2016-03-15 | 2021-10-12 | American University Of Beirut | Composition and use of macro-minerals to lower postprandial glycemic response and reduce body weight |
IT201900007338A1 (en) * | 2019-05-27 | 2020-11-27 | Pietro Tassone S N C Gia’ Tassone Antonio & C S N C | Bread making process |
Also Published As
Publication number | Publication date |
---|---|
KR101181876B1 (en) | 2012-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2564632C (en) | Flaxseeds for body weight management | |
US20090202674A1 (en) | Diet composition and method of preparing diet-food and pet-food therefrom | |
JP2007520205A (en) | High protein, low carbohydrate bakery products and other foods | |
US20060286240A1 (en) | Processing of teff flour | |
JP2002191292A (en) | Baked cake having high nutritive value | |
KR101181876B1 (en) | Composition for confectionery product or bread with low glycemic index and a method for preparing the same | |
CN102144651A (en) | Xylo-oligosaccharide crisp cookie and making method thereof | |
JP5931350B2 (en) | Baked confectionery having sleep improving action and premix for the baked confectionery | |
CN107307042A (en) | Low-calorie containing xylose, low-fat biscuit composition, by its making biscuit with and preparation method thereof | |
JP2012533286A (en) | Low glycemic index baked product with high levels of fiber, protein and inclusions | |
CN100500007C (en) | Premixed wheat flour for making steamed bread containing rich dietary fiber, and its production method | |
WO2020105935A1 (en) | High-protein bread and manufacturing method therefor | |
KR101859394B1 (en) | Manufacture method for bread of sticky rice contained a pea and a red bean | |
JP2013244012A (en) | Baked confectionery (chocolate cake) controlling rapid increase of blood sugar level for collecting contribution money for tohoku and method of manufacturing same | |
US20070054025A1 (en) | Novel dough methods for preparing the same and baking products thereof | |
KR20200095844A (en) | Composition for Mooncake and Manufacturing Method the Same | |
CN105519637A (en) | Making method of red mushroom biscuits | |
CN105941563A (en) | Highland barley and tartary buckwheat soft cake and preparing method thereof | |
WO2003086083A1 (en) | Diabetic, bran-free flour for the production of backing industry products, especially bread, pastries and cakes | |
RU2807698C1 (en) | Method of preparing corn and sweet potato churek (unleavened bread) | |
JPH10215758A (en) | Bread-like functional food, frozen dough and manufacture of bread-like functional food | |
KR102561661B1 (en) | Baking premix composition having low sugar and high protein capable of being fermented and method for preparing low calorie and sugar restricted bread using the same | |
US20130164407A1 (en) | Health bread based on non-grain flour | |
Zubairuddin et al. | Development and quality evaluation of ragi fortified cake | |
JP2014096995A (en) | New melon bun |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20150902 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170904 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |